Evidence map›Paper›PMID 41693044›Full record

ReviewChemical record (New York, N.Y.)2026

Catalytic Scalable Synthesis of Polyketides Enabled by Chiral Brønsted Acid-Catalyzed Asymmetric Allylborations.

Shigenobu Umemiya, Masahiro Terada

Abstract readReview
In one paragraph

Review in Chemical record (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shigenobu UmemiyaResearch and Analytical Center for Giant Molecules, Graduate School of Science, Tohoku University, Sendai, Miyagi, Japan.ORCID https://orcid.org/0000-0002-1793-856X
Masahiro TeradaDepartment of Chemistry,, Graduate School of Science, Tohoku University, Sendai, Miyagi, Japan.ORCID https://orcid.org/0000-0002-0554-8652

Funding

Grant-in-Aid for JP23H04908Grant-in-Aid for Scientific Research (C) 23K04730Grant-in-Aid for Scientific Research on Innovative Areas JP17H06447
6 · The paper itself

Abstract

The scalable synthesis of target molecules is essential for advancing applications, such as evaluating biological activity in pharmaceutical candidates and developing functional materials. In the context of medicinal chemistry, both industrial and academic researchers have achieved the scalable synthesis of diverse natural products and their derivatives, vastly boosting the development of pharmaceuticals. Most established scalable syntheses have conventionally relied on chiral pool approaches or stoichiometric asymmetric methodologies, and the use of catalytic asymmetric strategies has remained limited. In this personal account, we outline recent progress in the development and refinement of asymmetric allylboration reactions catalyzed by chiral Brønsted acids, providing important chiral building blocks that were previously difficult to access. We also describe the catalytic scalable synthesis of potent natural products enabled by the efficient preparation of chiral building blocks utilizing our allylboration reactions.

Indexed as

allylborationchiral Brønsted acidorganocatalystpolyketidesscalable synthesis

Identifiers

PMID41693044
PMCPMC13122441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.